Specify a stock or a cryptocurrency in the search bar to get a summary
NanoCarrier Co Ltd
4571NANO MRNA Co.,Ltd. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment in the area of tissue generation and vaccines; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers Complex, an antibacterial ear drops; cosmetic raw material, and platelet-rich therapy. The company was formerly known as NanoCarrier Co., Ltd. and changed its name to NANO MRNA Co.,Ltd. in June 2023. NANO MRNA Co.,Ltd. was incorporated in 1996 and is headquartered in Tokyo, Japan. Address: Atago Green Hills MORI Tower, Tokyo, Japan
Analytics
WallStreet Target Price
125 423.1 JPYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4571
Dividend Analytics 4571
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4571
Stock Valuation 4571
Financials 4571
Results | 2019 | Dynamics |